QuadraMed and WirelessMD, a subsidiary of M2Verticom, have signed an agreement to integrate WirelessMD’s Medical Data Retrieval System (MDRS) into QuadraMed’s Affinity healthcare information system. The MDRS will provide continuous remote
QuadraMed and WirelessMD, a subsidiary of M2Verticom, have signed an agreement to integrate WirelessMDs Medical Data Retrieval System (MDRS) into QuadraMeds Affinity healthcare information system. The MDRS will provide continuous remote access to real-time clinical data stored on Affinity systems to clinicians using interactive pagers, PDAs, and WAP-enabled cell phones, enabling users to receive relevant information and alerts via wireless technology. QuadraMed plans to market this wireless connectivity to its existing installed base of more than 4000 hospital sites. The firm claims implementation in over half of all U.S. hospitals.
In related news, M2Verticom has joined forces with Fujitsu-ICL Systems to supply wireless hardware and software to select vertical markets, including medical. Fujitsu-ICL will act as M2Verticoms preferred supplier of hardware for mobile computing, servers, desktops, laptops, and storage, while M2Verticom will provide wireless software applications and connectivity.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.